AMENDED AND RESTATED SENIOR MANAGEMENT AGREEMENTSenior Management Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • Delaware
This Agreement amends, restates and supersedes in its entirety that certain Senior Management Agreement, dated as of March 18, 2014 (the “Prior Agreement”), by and among the Company, Employer, Executive and The Eric Tardif and Tanya M. Kovacik Family Trust, dated June 2, 2010 (“Tardif Trust” and, together with Executive, each a “Tardif Party” and collectively, the “Tardif Parties”).
INVESTMENT AND DIRECTOR COMPENSATION AGREEMENTInvestment and Director Compensation Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTMENT AND DIRECTOR COMPENSATION AGREEMENT (this “Agreement”) is made as of January 8, 2020 by and among Maravai Life Sciences Holdings, LLC, a Delaware limited liability company (the “Company”), Gregory T. Lucier (“Director”) and RiverRoad Capital Partners, LLC, a Delaware limited liability company (“RiverRoad” and, together with Director, the “Director Parties”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in Section 8 of this Agreement, or if not defined herein, the meanings in the LLC Agreement.
THIRD AMENDMENT TO LEASE AGREEMENTLease Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • California
THIS LEASE AGREEMENT (this “Lease”) is made as of July , 2018 (“Effective Date”)’ by and between 10770 WATERIDGE INVESTORS LLC, a California limited liability company (“Landlord”), and TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (“Tenant”).
FIRST LIEN CREDIT AGREEMENTFirst Lien Credit Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • New York
This FIRST LIEN CREDIT AGREEMENT is entered into as of August 2, 2018, among MARAVAI INTERMEDIATE HOLDINGS, LLC, a Delaware limited liability company (“Parent Borrower”), CYGNUS TECHNOLOGIES, LLC, a Delaware limited liability company (“Cygnus”), TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (“TriLink”), Vector Laboratories, Inc., a California corporation (“Vector”; and together with the Parent Borrower, Cygnus and TriLink, the “Borrowers” and each, a “Borrower”), MARAVAI TOPCO HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), each L/C Issuer party hereto and JPMORGAN CHASE BANK, N.A. (“JPMCB”), as Administrative Agent and Collateral Agent.
FIFTH AMENDMENT TO DEED OF LEASEDeed of Lease • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • New York
THIS FIFTH AMENDMENT TO DEED OF LEASE (this “Amendment”) is made as of this 23rd day of September, 2019, (the “Effective Date”), by and between QUANTICO BUILDINGS, LLC, a Delaware limited liability company (“Landlord”), and GLEN RESEARCH CORPORATION, a Virginia corporation (“Tenant”).
SECOND LIEN CREDIT AGREEMENTLien Credit Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • New York
This SECOND LIEN CREDIT AGREEMENT is entered into as of August 2, 2018, among MARAVAI INTERMEDIATE HOLDINGS, LLC, a Delaware limited liability company (“Parent Borrower”), CYGNUS TECHNOLOGIES, LLC, a Delaware limited liability company (“Cygnus”), TRILINK BIOTECHNOLOGIES, LLC, a Delaware limited liability company (“TriLink”), Vector Laboratories, Inc., a California corporation (“Vector”; and together with the Parent Borrower, Cygnus and TriLink, the “Borrowers” and each, a “Borrower”), MARAVAI TOPCO HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and ANTARES CAPITAL LP (“Antares”), as Administrative Agent and Collateral Agent.
DISTRIBUTION AGREEMENTDistribution Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • California
This agreement (“Agreement”) is made and entered into on January 14, 2019 (“Effective Date”) between Cygnus Technologies, with a place of business at 4332 Southport Supply Rd., SE, Southport, NC 28461 USA (referred to herein as “Cygnus”), and BEIJING XMJ SCIENTIFIC CO., LTD, with a place of business at Rm 6C, Block C, Golden Resources Business Center, No.2 Landianchang East Rd, Haidian District, Beijing, China (referred to herein as “Distributor”), each a “Party” and together, the “Parties”.
SECOND AMENDED & RESTATED ADVISORY AGREEMENTAdvisory Agreement • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED & RESTATED ADVISORY AGREEMENT (this “Agreement”) is made as of September 15, 2016, by and among GTCR Management XI LP, a Delaware limited partnership (“GTCR”), Vector Laboratories, Inc., a California corporation (“Vector”), and TriLink BioTechnologies, LLC, a Delaware limited liability company (“TriLink” and, together with Vector, each an “Opco” and collectively “Opcos”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Limited Liability Company Agreement of the Company (as defined below), dated as of April 5, 2016, among the parties from time to time party thereto (as amended or modified from time to time, the “LLC Agreement”).
SENIOR MANAGEMENT AGREEMENTMaravai Lifesciences Holdings, Inc. • October 14th, 2020 • Pharmaceutical preparations • Delaware
THIS SENIOR MANAGEMENT AGREEMENT (this “Agreement”) is made as of December 27 , 2017, by and among Maravai Life Sciences Holdings, LLC, a Delaware limited liability company (the “Company”), TriLink Biotechnologies, LLC, a Delaware limited liability company (“Employer”), and Brian Neel (“Executive”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 8 of this Agreement, or if not defined herein, the meanings in the LLC Agreement.
SECOND AMENDMENT TO LEASELease • October 14th, 2020 • Maravai Lifesciences Holdings, Inc. • Pharmaceutical preparations • North Carolina
THIS SECOND AMENDMENT TO LEASE (“Amendment”) is made and entered into as of October 6, 2016, by and between ARAME, LLC, a North Carolina limited liability company (“Landlord”) and CYGNUS TECHNOLOGIES, INC., a North Carolina corporation (“Tenant”).
